Go Pro

Becton, Dickinson and Company (BDX) Competitors

Becton, Dickinson and Company logo
$176.80 -1.27 (-0.71%)
Closing price 03:59 PM Eastern
Extended Trading
$176.81 +0.01 (+0.01%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BDX vs. COO, HSIC, AMN, CAH, and DVA

Should you buy Becton, Dickinson and Company stock or one of its competitors? Becton, Dickinson and Company's main competitors and comparable companies include Cooper Companies (COO), Henry Schein (HSIC), AMN Healthcare Services (AMN), Cardinal Health (CAH), and DaVita (DVA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Becton, Dickinson and Company compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment.

Cooper Companies has a net margin of 13.46% compared to Becton, Dickinson and Company's net margin of 4.52%. Becton, Dickinson and Company's return on equity of 14.79% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies13.46% 10.90% 7.24%
Becton, Dickinson and Company 4.52%14.79%6.93%

Cooper Companies presently has a consensus target price of $71.47, suggesting a potential upside of 24.49%. Becton, Dickinson and Company has a consensus target price of $187.67, suggesting a potential upside of 6.18%. Given Cooper Companies' higher possible upside, analysts plainly believe Cooper Companies is more favorable than Becton, Dickinson and Company.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
2 Sell rating(s)
12 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.16
Becton, Dickinson and Company
0 Sell rating(s)
9 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.47

In the previous week, Cooper Companies had 24 more articles in the media than Becton, Dickinson and Company. MarketBeat recorded 32 mentions for Cooper Companies and 8 mentions for Becton, Dickinson and Company. Becton, Dickinson and Company's average media sentiment score of 0.77 beat Cooper Companies' score of 0.25 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
3 Very Positive mention(s)
5 Positive mention(s)
9 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Neutral
Becton, Dickinson and Company
4 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cooper Companies has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market. Comparatively, Becton, Dickinson and Company has a beta of 0.21, meaning that its stock price is 79% less volatile than the broader market.

Becton, Dickinson and Company has higher revenue and earnings than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B2.67$374.90M$2.9319.59
Becton, Dickinson and Company$21.84B2.23$1.68B$3.3253.24

24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are held by institutional investors. 2.1% of Cooper Companies shares are held by company insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Becton, Dickinson and Company beats Cooper Companies on 9 of the 16 factors compared between the two stocks.

How does Becton, Dickinson and Company compare to Henry Schein?

Becton, Dickinson and Company (NYSE:BDX) and Henry Schein (NASDAQ:HSIC) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, media sentiment, dividends, analyst recommendations, valuation, risk and profitability.

87.0% of Becton, Dickinson and Company shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 0.4% of Becton, Dickinson and Company shares are owned by insiders. Comparatively, 0.9% of Henry Schein shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Becton, Dickinson and Company has a net margin of 4.52% compared to Henry Schein's net margin of 2.96%. Henry Schein's return on equity of 15.97% beat Becton, Dickinson and Company's return on equity.

Company Net Margins Return on Equity Return on Assets
Becton, Dickinson and Company4.52% 14.79% 6.93%
Henry Schein 2.96%15.97%5.56%

Becton, Dickinson and Company has a beta of 0.21, indicating that its stock price is 79% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.84, indicating that its stock price is 16% less volatile than the broader market.

In the previous week, Becton, Dickinson and Company had 2 more articles in the media than Henry Schein. MarketBeat recorded 8 mentions for Becton, Dickinson and Company and 6 mentions for Henry Schein. Henry Schein's average media sentiment score of 0.89 beat Becton, Dickinson and Company's score of 0.77 indicating that Henry Schein is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Becton, Dickinson and Company
4 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Henry Schein
4 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Becton, Dickinson and Company currently has a consensus target price of $187.67, suggesting a potential upside of 6.18%. Henry Schein has a consensus target price of $92.93, suggesting a potential upside of 10.58%. Given Henry Schein's stronger consensus rating and higher probable upside, analysts plainly believe Henry Schein is more favorable than Becton, Dickinson and Company.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Becton, Dickinson and Company
0 Sell rating(s)
9 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.47
Henry Schein
1 Sell rating(s)
5 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.53

Becton, Dickinson and Company has higher revenue and earnings than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Becton, Dickinson and Company$21.84B2.23$1.68B$3.3253.24
Henry Schein$13.18B0.71$398M$3.4324.50

Summary

Henry Schein beats Becton, Dickinson and Company on 9 of the 16 factors compared between the two stocks.

How does Becton, Dickinson and Company compare to AMN Healthcare Services?

Becton, Dickinson and Company (NYSE:BDX) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, earnings, profitability, media sentiment, institutional ownership, risk and dividends.

Becton, Dickinson and Company currently has a consensus target price of $187.67, indicating a potential upside of 6.18%. AMN Healthcare Services has a consensus target price of $36.00, indicating a potential downside of 1.90%. Given Becton, Dickinson and Company's higher probable upside, equities analysts plainly believe Becton, Dickinson and Company is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Becton, Dickinson and Company
0 Sell rating(s)
9 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.47
AMN Healthcare Services
0 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Becton, Dickinson and Company has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Becton, Dickinson and Company$21.84B2.23$1.68B$3.3253.24
AMN Healthcare Services$2.73B0.52-$95.70M$2.6813.69

In the previous week, Becton, Dickinson and Company had 5 more articles in the media than AMN Healthcare Services. MarketBeat recorded 8 mentions for Becton, Dickinson and Company and 3 mentions for AMN Healthcare Services. AMN Healthcare Services' average media sentiment score of 0.83 beat Becton, Dickinson and Company's score of 0.77 indicating that AMN Healthcare Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Becton, Dickinson and Company
4 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Becton, Dickinson and Company has a net margin of 4.52% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat Becton, Dickinson and Company's return on equity.

Company Net Margins Return on Equity Return on Assets
Becton, Dickinson and Company4.52% 14.79% 6.93%
AMN Healthcare Services 3.06%19.92%5.93%

Becton, Dickinson and Company has a beta of 0.21, suggesting that its share price is 79% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, suggesting that its share price is 60% less volatile than the broader market.

87.0% of Becton, Dickinson and Company shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 0.4% of Becton, Dickinson and Company shares are held by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Becton, Dickinson and Company beats AMN Healthcare Services on 10 of the 16 factors compared between the two stocks.

How does Becton, Dickinson and Company compare to Cardinal Health?

Becton, Dickinson and Company (NYSE:BDX) and Cardinal Health (NYSE:CAH) are both large-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

Becton, Dickinson and Company currently has a consensus target price of $187.67, indicating a potential upside of 6.18%. Cardinal Health has a consensus target price of $266.56, indicating a potential upside of 17.68%. Given Cardinal Health's stronger consensus rating and higher possible upside, analysts clearly believe Cardinal Health is more favorable than Becton, Dickinson and Company.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Becton, Dickinson and Company
0 Sell rating(s)
9 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.47
Cardinal Health
0 Sell rating(s)
3 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
2.84

87.0% of Becton, Dickinson and Company shares are owned by institutional investors. Comparatively, 87.2% of Cardinal Health shares are owned by institutional investors. 0.4% of Becton, Dickinson and Company shares are owned by insiders. Comparatively, 0.1% of Cardinal Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Becton, Dickinson and Company has a beta of 0.21, meaning that its share price is 79% less volatile than the broader market. Comparatively, Cardinal Health has a beta of 0.5, meaning that its share price is 50% less volatile than the broader market.

In the previous week, Cardinal Health had 10 more articles in the media than Becton, Dickinson and Company. MarketBeat recorded 18 mentions for Cardinal Health and 8 mentions for Becton, Dickinson and Company. Becton, Dickinson and Company's average media sentiment score of 0.77 beat Cardinal Health's score of 0.39 indicating that Becton, Dickinson and Company is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Becton, Dickinson and Company
4 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cardinal Health
4 Very Positive mention(s)
2 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Becton, Dickinson and Company has a net margin of 4.52% compared to Cardinal Health's net margin of 0.67%. Becton, Dickinson and Company's return on equity of 14.79% beat Cardinal Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Becton, Dickinson and Company4.52% 14.79% 6.93%
Cardinal Health 0.67%-98.53%4.69%

Cardinal Health has higher revenue and earnings than Becton, Dickinson and Company. Cardinal Health is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Becton, Dickinson and Company$21.84B2.23$1.68B$3.3253.24
Cardinal Health$254.25B0.21$1.71B$7.2331.33

Becton, Dickinson and Company pays an annual dividend of $4.20 per share and has a dividend yield of 2.4%. Cardinal Health pays an annual dividend of $2.06 per share and has a dividend yield of 0.9%. Becton, Dickinson and Company pays out 126.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cardinal Health pays out 28.5% of its earnings in the form of a dividend. Becton, Dickinson and Company has increased its dividend for 53 consecutive years and Cardinal Health has increased its dividend for 29 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Cardinal Health beats Becton, Dickinson and Company on 10 of the 19 factors compared between the two stocks.

How does Becton, Dickinson and Company compare to DaVita?

Becton, Dickinson and Company (NYSE:BDX) and DaVita (NYSE:DVA) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk.

87.0% of Becton, Dickinson and Company shares are owned by institutional investors. Comparatively, 90.1% of DaVita shares are owned by institutional investors. 0.4% of Becton, Dickinson and Company shares are owned by company insiders. Comparatively, 1.9% of DaVita shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

DaVita has a net margin of 6.05% compared to Becton, Dickinson and Company's net margin of 4.52%. Becton, Dickinson and Company's return on equity of 14.79% beat DaVita's return on equity.

Company Net Margins Return on Equity Return on Assets
Becton, Dickinson and Company4.52% 14.79% 6.93%
DaVita 6.05%-217.63%5.07%

Becton, Dickinson and Company has higher revenue and earnings than DaVita. DaVita is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Becton, Dickinson and Company$21.84B2.23$1.68B$3.3253.24
DaVita$13.64B0.84$746.80M$12.2214.68

Becton, Dickinson and Company has a beta of 0.21, meaning that its share price is 79% less volatile than the broader market. Comparatively, DaVita has a beta of 0.8, meaning that its share price is 20% less volatile than the broader market.

Becton, Dickinson and Company presently has a consensus target price of $187.67, suggesting a potential upside of 6.18%. DaVita has a consensus target price of $233.43, suggesting a potential upside of 30.15%. Given DaVita's higher possible upside, analysts clearly believe DaVita is more favorable than Becton, Dickinson and Company.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Becton, Dickinson and Company
0 Sell rating(s)
9 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.47
DaVita
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43

In the previous week, Becton, Dickinson and Company had 4 more articles in the media than DaVita. MarketBeat recorded 8 mentions for Becton, Dickinson and Company and 4 mentions for DaVita. Becton, Dickinson and Company's average media sentiment score of 0.77 beat DaVita's score of 0.00 indicating that Becton, Dickinson and Company is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Becton, Dickinson and Company
4 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
DaVita
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Becton, Dickinson and Company beats DaVita on 10 of the 16 factors compared between the two stocks.

Get Becton, Dickinson and Company News Delivered to You Automatically

Sign up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BDX vs. The Competition

MetricBecton, Dickinson and CompanyHealthcare Equipment & Supplies IndustryHealthcare SectorNYSE Exchange
Market Cap$49.07B$5.36B$7.09B$22.70B
Dividend Yield2.36%1.80%2.53%3.74%
P/E Ratio53.2524.66274.6127.75
Price / Sales2.2341.72600.5120.15
Price / Cash7.7232.6877.3839.56
Price / Book2.005.6810.924.64
Net Income$1.68B$152.11M$3.50B$1.08B
7 Day Performance-3.66%-2.01%-2.11%-1.06%
1 Month Performance-5.75%-5.42%-6.34%-5.03%
1 Year Performance-7.64%2.75%8.81%5.78%

Becton, Dickinson and Company Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BDX
Becton, Dickinson and Company
3.346 of 5 stars
$176.80
-0.7%
$187.67
+6.1%
-6.8%$49.07B$21.84B53.2572,000
COO
Cooper Companies
4.346 of 5 stars
$56.57
+2.1%
$71.47
+26.3%
-15.7%$10.53B$4.09B19.3115,000
HSIC
Henry Schein
3.2882 of 5 stars
$85.99
-0.4%
$92.93
+8.1%
+29.5%$9.63B$13.18B25.0725,000
AMN
AMN Healthcare Services
1.4415 of 5 stars
$34.20
-1.0%
$36.00
+5.3%
+80.0%$1.34B$2.73B12.762,664
CAH
Cardinal Health
4.767 of 5 stars
$220.12
0.0%
$266.56
+21.1%
+45.9%$50.99B$254.25B30.4563,900

Related Companies and Tools


This page (NYSE:BDX) was last updated on 10/2/2026 by MarketBeat.com Staff.
From Our Partners